Helius Medical Technologies, Inc. Announces Positive Preliminary Results of the PoNSTEP Study
by GlobeNewswire
Sep 30, 2024 8:09 pm
-- Achieves primary endpoint showing a linear relationship between adherence to PoNS Therapy® in Phase 2 and improvement in DGI scores from Phase 1 to end of treatment at week 14 --
-- Confirms the therapeutic benefits of PoNS Therapy for gait deficit improvement in people with MS --